Casandra
Casandra Test Code PG66324Version 1 (DRAFT)
Performing Lab
Optic Atrophy and Hereditary Spastic Paraplegia via the SPG7 Gene
Clinical Use
Order TestUse
This test is for individuals with clinical or suspected diagnosis of optic atrophy or hereditary spastic paraplegia. It is also relevant for reproductive partners of individuals with a known pathogenic variant in the SPG7 gene.
Special Instructions
Not provided.
Limitations
Results are influenced by the quality of the clinical information provided. Tests are developed and validated per CAP and CLIA regulations but not cleared or approved by the US FDA. These technical limitations should be considered when interpreting the results.
Test Details
New York Approved
Methodology
NGS
Biomarkers
NGS with CNV
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided